Clinical trials update: highlights of the scientific sessions of the American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL

被引：49

作者：

Coletta, A ^{[1
]}

Thackray, S ^{[1
]}

Nikitin, N ^{[1
]}

Cleland, JGF ^{[1
]}

机构：

[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2002年 / 4卷 / 03期

关键词：

LIFE; DANAMI; 2; MADIT-2; MIRACLE-ICD; OVERTURE; OCTAVE; ENABLE 1 & 2; CHRISTMAS; AFFIRM; RACE; WIZARD; AZACS; REMATCH; BNP trial; HARDBALL;

D O I：

10.1016/S1388-9842(02)00040-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the American College of Cardiology 51st Annual Scientific Session held in Atlanta on 17-20 March 2002. Reports of the following clinical studies are included: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE I & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. (C) 2002 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.

引用

页码：381 / 388

页数：8

共 14 条

[1] Expanding indications for implantable cardiac defibrillators
Bigger, JT
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) : 931 - 933
[2] BOCHMER JP, 2002, J AM COLL CARDIOL, V39, pA159
[3] The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)
Cleland, JGF
Pennel, D
Ray, S
Murray, G
MacFarlane, P
Cowley, A
Coats, A
Lahiri, A
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (02) : 191 - 196
[4] Outcome studies with device therapy in patients with heart failure
Cleland, JGF
Thackray, S
Goodge, L
Kaye, G
Cooklin, M
[J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (01) : S73 - S91
[5] Risk stratification in chronic heart failure
Cowburn, PJ
Cleland, JGF
Coats, AJS
Komajda, M
[J]. EUROPEAN HEART JOURNAL, 1998, 19 (05) : 696 - 710
[6] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
Dahlöf, B
Devereux, RB
Kjeldsen, SE
Julius, S
Beevers, G
de Faire, U
Fyhrquist, F
Ibsen, H
Kristiansson, K
Lederballe-Pedersen, O
Lindholm, LH
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
[J]. LANCET, 2002, 359 (9311) : 995 - 1003
[7] Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%
Grimm, W
Hoffmann, J
Müller, HH
Maisch, B
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 780 - 787
[8] Systematic review of the management of atrial fibrillation in patients with heart failure
Khand, AU
Rankin, AC
Kaye, GC
Cleland, JGF
[J]. EUROPEAN HEART JOURNAL, 2000, 21 (08) : 614 - 632
[9] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
Lindholm, LH
Ibsen, H
Dahlöf, B
Devereux, RB
Beevers, G
de Faire, U
Fyhrquist, F
Julius, S
Kjeldsen, SE
Kristiansson, K
Lederballe-Pedersen, O
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
Aurup, P
Edelman, J
Snapinn, S
[J]. LANCET, 2002, 359 (9311) : 1004 - 1010
[10] Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
Louis, A
Cleland, JGF
Crabbe, S
Ford, S
Thackray, S
Houghton, T
Clark, A
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) : 381 - 387

← 1 2 →